Health Direct- NHS news, advice and information

Recent Posts

Tag Cloud

Site search

Site menu:

Archives

HON- Accreditation

The Health Direct blog adheres to the eight principles of the Health On the Net’s HON Code of Conduct (HONcode) for medical and health websites.

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information: verify here.
The Health Direct listing on MedHunt, Health On the Net’s medical search engine: http://www.hon.ch/cgi-bin/update.pl?HON17856

Categories

Links:

HEALTH TWITTER

Recent Comments

Tag: Multiple Sclerosis

MS sufferers have new drug hope by quango

The first pill for MS sufferers is set to be approved for use on the NHS.The National Institute for Curbing Expendtiture (NICE) has overturned previous draft guidance on the drug Fingolimod after the price was discounted and has now ruled that a proportion of people with multiple sclerosis should be treated with it. MS is […]

Study backs use of cannabis based Sativex to treat Multiple Sclerosis

The results of a Phase III trial have shown the ability of GW Pharmaceuticals’ cannabinoid based medicine Sativex to reduce severe spasticity associated with Multiple Sclerosis. According to the data, published in the European Journal of Neurology, about half of MS patients who had failed to respond to standard therapy experienced an improvement in spasticity […]

Nanny state advice on suntanning may mean vitamin D deficiency risk

Concerns over the link between rising skin cancer rates and exposure to sunshine may have led to overly precautionary advice being given to the public about staying out of the sun at midday, according to a confidential “position statement” by leading health organisations. The current advice to the public from the leading research charity on […]

MS sufferers welcome first licensed cannabis based drug

The first licensed medical drug containing whole cannabis plant extracts has been launched to treat symptoms of multiple sclerosis (MS). Sativex will be made widely available after it was approved by the medicines regulator last week. Taken as a mouth spray, it is used to help alleviate symptoms of spasticity – involuntary muscle stiffness and […]